CD300A and cutaneous melanoma: We further analyzed the database of the Cancer Genome Atlas (TCGA) project and found that skin cutaneous melanoma (SKCM) patients expressing low levels of CD300A mRNA had shorter survival times than did those expressing higher CD300A mRNA levels (Figure 6A).